The Ahmedabad-based drug maker will submit the outcomes of its phase-2 trials next week, which “will determine the safety, dosage and efficacy of the potential vaccine”, stated the individual who requested not to be determined.
Find Out More
Zydus Cadila to make an application for Phase-3 trials in December, wishes to launch vaccine by March
Byindianadmin
Nov 27, 2020